These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 29322868)
1. In silico approaches to evaluate the molecular properties of organophosphate compounds to inhibit acetylcholinesterase activity in housefly. Marimuthu P; Lee YJ; Kim B; Seo SS J Biomol Struct Dyn; 2019 Feb; 37(2):307-320. PubMed ID: 29322868 [TBL] [Abstract][Full Text] [Related]
2. Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease. Gurung AB; Aguan K; Mitra S; Bhattacharjee A J Biomol Struct Dyn; 2017 Jun; 35(8):1729-1742. PubMed ID: 27410776 [TBL] [Abstract][Full Text] [Related]
3. A mechanism-based 3D-QSAR approach for classification and prediction of acetylcholinesterase inhibitory potency of organophosphate and carbamate analogs. Lee S; Barron MG J Comput Aided Mol Des; 2016 Apr; 30(4):347-63. PubMed ID: 27055524 [TBL] [Abstract][Full Text] [Related]
4. Development of 3D-QSAR Model for Acetylcholinesterase Inhibitors Using a Combination of Fingerprint, Molecular Docking, and Structure-Based Pharmacophore Approaches. Lee S; Barron MG Toxicol Sci; 2015 Nov; 148(1):60-70. PubMed ID: 26202430 [TBL] [Abstract][Full Text] [Related]
5. Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches. Ojo OA; Ojo AB; Okolie C; Nwakama MC; Iyobhebhe M; Evbuomwan IO; Nwonuma CO; Maimako RF; Adegboyega AE; Taiwo OA; Alsharif KF; Batiha GE Molecules; 2021 Apr; 26(7):. PubMed ID: 33915968 [TBL] [Abstract][Full Text] [Related]
6. Quantitative structure-activity relationship of organophosphate compounds based on molecular interaction fields descriptors. Zhao J; Yu S Environ Toxicol Pharmacol; 2013 Mar; 35(2):228-34. PubMed ID: 23348103 [TBL] [Abstract][Full Text] [Related]
7. Combined 3D-QSAR, molecular docking, and molecular dynamics study of tacrine derivatives as potential acetylcholinesterase (AChE) inhibitors of Alzheimer's disease. Zhou A; Hu J; Wang L; Zhong G; Pan J; Wu Z; Hui A J Mol Model; 2015 Oct; 21(10):277. PubMed ID: 26438408 [TBL] [Abstract][Full Text] [Related]
8. Pharmacophore generation, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on benzamide analogues as FtsZ inhibitors. Tripathy S; Azam MA; Jupudi S; Sahu SK J Biomol Struct Dyn; 2018 Sep; 36(12):3218-3230. PubMed ID: 28938860 [TBL] [Abstract][Full Text] [Related]
9. The discovery of new acetylcholinesterase inhibitors derived from pharmacophore modeling, virtual screening, docking simulation and bioassays. Zhang Y; Zhang S; Xu G; Yan H; Pu Y; Zuo Z Mol Biosyst; 2016 Nov; 12(12):3734-3742. PubMed ID: 27801451 [TBL] [Abstract][Full Text] [Related]
10. Molecular dynamics simulation study and molecular docking descriptors in structure-based QSAR on acetylcholinesterase (AChE) inhibitors. Gharaghani S; Khayamian T; Ebrahimi M SAR QSAR Environ Res; 2013; 24(9):773-94. PubMed ID: 23863115 [TBL] [Abstract][Full Text] [Related]
11. Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease. Son M; Park C; Rampogu S; Zeb A; Lee KW Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823604 [TBL] [Abstract][Full Text] [Related]
12. Exploring molecular structural requirement for AChE inhibition through multi-chemometric and dynamics simulation analyses. Hossain T; Saha A; Mukherjee A J Biomol Struct Dyn; 2018 Apr; 36(5):1274-1285. PubMed ID: 28417668 [TBL] [Abstract][Full Text] [Related]
13. Deciphering the crucial molecular properties of a series of Benzothiazole Hydrazone inhibitors that targets anti-apoptotic Bcl-xL protein. Marimuthu P; Balasubramanian PK; Singaravelu K J Biomol Struct Dyn; 2018 Aug; 36(10):2654-2667. PubMed ID: 28793831 [TBL] [Abstract][Full Text] [Related]
14. Identification of novel acetylcholinesterase inhibitors through 3D-QSAR, molecular docking, and molecular dynamics simulation targeting Alzheimer's disease. El Khatabi K; El-Mernissi R; Aanouz I; Ajana MA; Lakhlifi T; Khan A; Wei DQ; Bouachrine M J Mol Model; 2021 Sep; 27(10):302. PubMed ID: 34581863 [TBL] [Abstract][Full Text] [Related]
15. QSAR analyses of organophosphates for insecticidal activity and its in-silico validation using molecular docking study. Niraj RR; Saini V; Kumar A Environ Toxicol Pharmacol; 2015 Nov; 40(3):886-94. PubMed ID: 26492451 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches. Pang X; Fu H; Yang S; Wang L; Liu AL; Wu S; Du GH Molecules; 2017 Jul; 22(8):. PubMed ID: 28933746 [TBL] [Abstract][Full Text] [Related]
17. Dynamic structure based pharmacophore modeling of the Acetylcholinesterase reveals several potential inhibitors. Shiri F; Pirhadi S; Ghasemi JB J Biomol Struct Dyn; 2019 Apr; 37(7):1800-1812. PubMed ID: 29695192 [TBL] [Abstract][Full Text] [Related]
18. In-silico and in-vitro evaluation of human acetylcholinesterase inhibition by organophosphates. Ranjan A; Chauhan A; Jindal T Environ Toxicol Pharmacol; 2018 Jan; 57():131-140. PubMed ID: 29272792 [TBL] [Abstract][Full Text] [Related]
19. Identification of novel acetylcholinesterase inhibitors through e-pharmacophore-based virtual screening and molecular dynamics simulations. Malik R; Choudhary BS; Srivastava S; Mehta P; Sharma M J Biomol Struct Dyn; 2017 Nov; 35(15):3268-3284. PubMed ID: 27782777 [TBL] [Abstract][Full Text] [Related]
20. The reactivation of tabun-inhibited mutant AChE with Ortho-7: steered molecular dynamics and quantum chemical studies. Lo R; Chandar NB; Ghosh S; Ganguly B Mol Biosyst; 2016 Apr; 12(4):1224-31. PubMed ID: 26879641 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]